Thu, Nov 21, 2024
[Archive]
Volume 1, Issue 1 (Autumn 2022)
CPR 2022, 1(1): 84-99 |
Back to browse issues page
Ethics code: IR.KMU.AH.REC.1398.129
Clinical trials code: NA
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Divsalar P, Zamani Zadeh S, Gozashti M H. Suicidal Ideation and Depression in Hospitalized Patients With Metabolic Syndrome. CPR 2022; 1 (1) :84-99
URL: http://cpr.mazums.ac.ir/article-1-22-en.html
URL: http://cpr.mazums.ac.ir/article-1-22-en.html
Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Abstract: (2153 Views)
Background and Objective: The increase in the global prevalence of metabolic syndrome has become a major public health problem. Few studies have been conducted on the relationship between psychiatric disorders and metabolic syndrome in Iran; therefore, we investigated the association between depression and suicidal ideation amongst patients with metabolic syndrome.
Materials & Method: This study was a descriptive cross-sectional study to determine the prevalence of depression and suicidal ideation among 150 patients with metabolic syndrome referred to the Endocrinology Department of Afzalipour General Hospital, Kerman City, Iran, in 2019. The study data were obtained using the Beck scale for suicide ideation, Beck Depression Inventory (BDI-II), and demographic information questionnaire. The last hemoglobin (Hb) A1C test, body mass index (BMI), blood pressure, high-density lipoprotein (HDL), cholesterol, triglyceride test, and waist circumference were gathered according to ATP III guidelines. Analyses of variance, the t test, the Pearson test, multiple regression, and the Spearman test were performed for statistical analyses.
Results: About 52.6% of participants were male, 87.3% were married, and 77.4% lived in the city. Also, 59.4% had depression, and suicidal ideation was prevalent among them: 50% of the samples had suicide ideation, and 8% were ready to commit suicide. There were significant positive correlations between suicide ideation and mean age, duration of illness, BMI, mean HbA1C level, fasting blood sugar (FBS), and depression, but there was a significant negative correlation between suicide score and HDL level.
Conclusion: Awareness of these factors can help identify high-risk people. It is suggested that particular consideration be given to the various dimensions of psychiatric issues related to people with metabolic syndrome.
Materials & Method: This study was a descriptive cross-sectional study to determine the prevalence of depression and suicidal ideation among 150 patients with metabolic syndrome referred to the Endocrinology Department of Afzalipour General Hospital, Kerman City, Iran, in 2019. The study data were obtained using the Beck scale for suicide ideation, Beck Depression Inventory (BDI-II), and demographic information questionnaire. The last hemoglobin (Hb) A1C test, body mass index (BMI), blood pressure, high-density lipoprotein (HDL), cholesterol, triglyceride test, and waist circumference were gathered according to ATP III guidelines. Analyses of variance, the t test, the Pearson test, multiple regression, and the Spearman test were performed for statistical analyses.
Results: About 52.6% of participants were male, 87.3% were married, and 77.4% lived in the city. Also, 59.4% had depression, and suicidal ideation was prevalent among them: 50% of the samples had suicide ideation, and 8% were ready to commit suicide. There were significant positive correlations between suicide ideation and mean age, duration of illness, BMI, mean HbA1C level, fasting blood sugar (FBS), and depression, but there was a significant negative correlation between suicide score and HDL level.
Conclusion: Awareness of these factors can help identify high-risk people. It is suggested that particular consideration be given to the various dimensions of psychiatric issues related to people with metabolic syndrome.
Type of Study: Research |
Subject:
Endocrine diseases
Received: 2022/06/1 | Accepted: 2022/11/1 | Published: 2022/10/1
Received: 2022/06/1 | Accepted: 2022/11/1 | Published: 2022/10/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Address: Mazandaran University of Medical Sciences, Moallem Square, Sari, Iran.
Journal Office Tel: +981134343407
Email: cpr
mazums.ac.ir
Publisher: Negah Institute for Social Research & Scientific Communication
Publisher Tel: +9821 4535 5555; +9821 4535 5000
